GALLEONBIO

GalleonBio is a mid-stage biopharmaceutical company focusing on the development of novel topical therapies for the management of inflammatory dermatological, neuropathic pain and other conditions. Based on multiple years of research and scientific innovation in rare earth metals, GalleonBio's scientists have developed a unique therapeutic technology platform of products containing strontium. Based in the USA GalleonBio are implementing a worldwide clinical development program to support it's patented advances reaching patients in multiple disease states globally. Alternative routes of administration to treat additional indications are also being tested... Galleon Bio LLC is an original research and pre-clinical organization that has taken rare earth metals and investigated their tremendous clinical potential in animal models. Galleon has a novel strontium based cream which is showing promise in multiple skin models in animals and early stage human testing.

Also known as: Galleon Bio LLC

Primary location: Newark United States